Myechia Minter-Jordan, MD, and Lisa Simon, MD, DMD, recently joined two dentists to testify before the U.S. Senate Committee on Health, Education, Labor and Pensions about how to improve dental care ...

Alzheon says it expects to fund the completion of a pivotal Phase III trial and regulatory filings later this year for its ...

Several promising drugs in phase 2 testing and beyond seek to offer patients a more convenient alternative to already popular ...

The single-dose oral suspension also had a high microbiological cure rate ... His colleague Alison Luckey, MD, senior medical ...

Myechia Minter-Jordan, MD, is an internal medicine physician and the president and CEO of the CareQuest Institute for Oral Health. She recently joined three other doctors in testifying before the U.S.

New research argues that the oral alternative to injected semaglutide could also help improve the symptoms of diabetes and ...

Arghavan Salles, MD, PhD, polled her audience on X: why are health workers still active on social media platforms that allow ...

Patients with atrial fibrillation (Afib) who took low doses of blood-thinning medications known as direct oral anticoagulants ...

Experts share what they are looking forward to most at this year's European Hematology Association (EHA) Congress.

The safety profile of 200 milligrams and 300 milligrams of oral Ongureg were similar in patients with lower- to ...

Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic ...

I-Mab (NASDAQ: IMAB) (the "Company"), a U.S.-based, global biotech company, exclusively focused on the development and ...